🎉 M&A multiples are live!
Check it out!

Novanta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Novanta and similar public comparables like Myomo, InfuSystem, and SmartVest.

Novanta Overview

About Novanta

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.


Founded

1970

HQ

United States of America
Employees

3K+

Website

novanta.com

Financials

LTM Revenue $963M

LTM EBITDA $216M

EV

$4.5B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Novanta Financials

Novanta has a last 12-month revenue of $963M and a last 12-month EBITDA of $216M.

In the most recent fiscal year, Novanta achieved revenue of $949M and an EBITDA of $180M.

Novanta expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Novanta valuation multiples based on analyst estimates

Novanta P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $882M $949M XXX XXX XXX
Gross Profit $378M $400M XXX XXX XXX
Gross Margin 43% 42% XXX XXX XXX
EBITDA $170M $180M XXX XXX XXX
EBITDA Margin 19% 19% XXX XXX XXX
Net Profit $74.1M $72.9M XXX XXX XXX
Net Margin 8% 8% XXX XXX XXX
Net Debt $335M $249M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Novanta Stock Performance

As of April 15, 2025, Novanta's stock price is $114.

Novanta has current market cap of $4.1B, and EV of $4.5B.

See Novanta trading valuation data

Novanta Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.5B $4.1B XXX XXX XXX XXX $3.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Novanta Valuation Multiples

As of April 15, 2025, Novanta has market cap of $4.1B and EV of $4.5B.

Novanta's trades at 4.6x LTM EV/Revenue multiple, and 20.7x LTM EBITDA.

Analysts estimate Novanta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Novanta and 10K+ public comps

Novanta Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $4.5B XXX XXX XXX
EV/Revenue 4.7x XXX XXX XXX
EV/EBITDA 24.9x XXX XXX XXX
P/E 64.2x XXX XXX XXX
P/E/Growth 1.7x XXX XXX XXX
EV/FCF 31.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Novanta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Novanta Valuation Multiples

Novanta's NTM/LTM revenue growth is 6%

Novanta's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Novanta's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Novanta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Novanta and other 10K+ public comps

Novanta Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 8% XXX XXX XXX XXX
EBITDA Margin 19% XXX XXX XXX XXX
EBITDA Growth 6% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 25% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 31% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Novanta Public Comps

See public comps and valuation multiples for Medical Devices and Robotics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Novanta M&A and Investment Activity

Novanta acquired  XXX companies to date.

Last acquisition by Novanta was  XXXXXXXX, XXXXX XXXXX XXXXXX . Novanta acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Novanta

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Novanta

When was Novanta founded? Novanta was founded in 1970.
Where is Novanta headquartered? Novanta is headquartered in United States of America.
How many employees does Novanta have? As of today, Novanta has 3K+ employees.
Who is the CEO of Novanta? Novanta's CEO is Mr. Matthijs Glastra.
Is Novanta publicy listed? Yes, Novanta is a public company listed on NAS.
What is the stock symbol of Novanta? Novanta trades under NOVT ticker.
When did Novanta go public? Novanta went public in 1999.
Who are competitors of Novanta? Similar companies to Novanta include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Novanta? Novanta's current market cap is $4.1B
What is the current revenue of Novanta? Novanta's last 12-month revenue is $963M.
What is the current EBITDA of Novanta? Novanta's last 12-month EBITDA is $216M.
What is the current EV/Revenue multiple of Novanta? Current revenue multiple of Novanta is 4.6x.
What is the current EV/EBITDA multiple of Novanta? Current EBITDA multiple of Novanta is 20.7x.
What is the current revenue growth of Novanta? Novanta revenue growth between 2023 and 2024 was 8%.
Is Novanta profitable? Yes, Novanta is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.